Sign in with Google. Opens in new tab
ENTITY
SMARTSCORE: 3.8/5
Genscript Biotech

Genscript Biotech (1548 HK)

81
Analysis
Health CareHong Kong
Genscript Biotech Corp is biotech service company. The Company provides life science services and products and pre-clinical drug development services.
more
23 Jul 2025 00:55

What Happens to China Healthcare? - The Soaring Shares, the Turning Point, and the Top Picks

China biotech is the biggest valuation driver for the industry, but primary market still lacks confidence in long-term outlook. Valuation bubble...

Logo
248 Views
Share
13 Nov 2024 05:10

StubWorld: Hanwha Corp; Genscript Biotech/Legend Biotech

Hanwha Corp appears attractive here. The pushback is that HC is thinly traded. And Genscript’s  deconsolidation has minimal impact on financials...

Logo
351 Views
Share
16 Jul 2025 00:55

Ascentage Pharma (6855.HK) Placement - Thoughts on The Placing Price and the Outlook

The Placing price of HK$68.6 has priced in successful licensing deal of APG-2575. US$1.5-2.375bn is a more reasonable valuation. Biotech sector...

Logo
329 Views
Share
30 Jun 2025 00:55

Pre-IPO China Medical System (867 HK) - About the IPO in Singapore and Concerns on Valuation Outlook

Listing in SGX opens a new chapter and CMS is undergoing pipeline adjustments and strategic transformation. But as valuation logic changes, license...

Logo
343 Views
Share
29 Jun 2025 01:19

China Healthcare Weekly (Jun.29) - Biotech Valuation Bubble Is About to Burst, Innovent's Placement

The valuation bubble of innovative drug companies may burst soon, with some founders/shareholders already cashing out. Innovent's Placing Price of...

Logo
310 Views
Share
x